Daclahep (DAKLINZA) Daclatasvir 60mg online
Roll over image to zoom in
$132.00
Sustainedvirologicresponse(SVR12)ratesarereducedingenotype3patientswith cirrhosis receiving Daclatasvir 60mg in combination with sofosbuvir for 12 weeks.
Daclahep (Daclatasvir 60mg) is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection. Limitations of Use:
•Sustainedvirologicresponse(SVR12)ratesarereducedingenotype3patientswith cirrhosis receiving Daclatasvir 60mg in combination with sofosbuvir for 12 weeks.
